Biohub brings tech and government into its virtual-cell bet

Biohub, the nonprofit research group founded by Mark Zuckerberg and Priscilla Chan, says its five-year Virtual Biology Initiative now has nearly $1.8 billion in combined commitments after U.S. agencies, Google and other partners joined. A collective $300 million pledge comes from Google DeepMind, Meta and Isomorphic Labs, Alphabet’s drug-discovery company; the larger figure also includes data, computing resources and measurement technology, not just cash. The goal is a “virtual cell”: an AI system trained on vast, standardized datasets to forecast how a living cell might respond to a drug, genetic change or other intervention. That could help researchers rule out weaker ideas on a computer before spending time and money in the lab, though current models still lack the breadth of data needed to simulate a whole cell reliably.